Showing results (261-270 of 454) with videos related to
Sort By:
Pageof 46
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2015
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic LeukemiaChristopher R Flowers, Jennifer R Brown, Hilary Rosenthal, et al.Blood|February 28, 2002
A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantationLeslie S Kean, Megan M Durham, Andrew B Adams, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2018
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation OutcomesMojibade Hassan, Alina Ulezko Antonova, Jian Ming Li, et al.Vascular Medicine (London, England)|September 5, 2022
The association between baseline circulating progenitor cells and vascular function: The role of aging and risk factorsKasra Moazzami, Anurag Mehta, An Young, et al.Blood|October 7, 2022
mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopeniasDeepak Kumar, Thinh H Nguyen, Carolyn M Bennett, et al.Bone Marrow Transplantation|February 14, 2012
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trialM H Jagasia, R Abonour, G D Long, et al.Leukemia & Lymphoma|July 6, 2012
Tools to optimize the functionality of a leukemia clinical trial teamBeverly Bethelmie-Bryan, Katharine Lord, Stacie Holloway, et al.Journal of Clinical Apheresis|May 28, 2024
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G-CSF and Plerixafor: A single center projectAyda Javanbakht, Stephanie Stringer, Hollie Anderson, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantationJohn D Roback, Mohammad S Hossain, Levan Lezhava, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor programSergio Giralt, Brent Logan, Douglas Rizzo, et al.Pageof 46